X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with ASTRAZENECA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs ASTRAZENECA PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD ASTRAZENECA PHARMA MERCK LTD/
ASTRAZENECA PHARMA
 
P/E (TTM) x 26.8 91.9 29.2% View Chart
P/BV x 3.0 13.1 22.9% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 MERCK LTD   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
ASTRAZENECA PHARMA
Mar-14
MERCK LTD/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0601,285 82.5%   
Low Rs623634 98.3%   
Sales per share (Unadj.) Rs632.4189.6 333.6%  
Earnings per share (Unadj.) Rs45.7-0.2 -22,454.3%  
Cash flow per share (Unadj.) Rs62.33.8 1,620.9%  
Dividends per share (Unadj.) Rs11.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs388.868.6 566.5%  
Shares outstanding (eoy) m16.6025.00 66.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.35.1 26.3%   
Avg P/E ratio x18.4-4,712.7 -0.4%  
P/CF ratio (eoy) x13.5249.6 5.4%  
Price / Book Value ratio x2.214.0 15.5%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,96923,988 58.2%   
No. of employees `0001.61.6 101.5%   
Total wages/salary Rs m1,4871,605 92.7%   
Avg. sales/employee Rs Th6,631.93,040.2 218.1%   
Avg. wages/employee Rs Th939.21,029.2 91.2%   
Avg. net profit/employee Rs Th479.4-3.3 -14,683.6%   
INCOME DATA
Net Sales Rs m10,4984,740 221.5%  
Other income Rs m24292 263.2%   
Total revenues Rs m10,7414,832 222.3%   
Gross profit Rs m1,135-130 -874.7%  
Depreciation Rs m276101 272.2%   
Interest Rs m00-   
Profit before tax Rs m1,102-139 -793.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0139 0.0%   
Tax Rs m3435 6,744.6%   
Profit after tax Rs m759-5 -14,909.6%  
Gross profit margin %10.8-2.7 -394.9%  
Effective tax rate %31.1-3.7 -850.0%   
Net profit margin %7.2-0.1 -6,731.3%  
BALANCE SHEET DATA
Current assets Rs m6,4102,726 235.1%   
Current liabilities Rs m8,8282,435 362.6%   
Net working cap to sales %-23.06.1 -374.8%  
Current ratio x0.71.1 64.8%  
Inventory Days Days5874 78.2%  
Debtors Days Days3841 94.2%  
Net fixed assets Rs m1,4061,035 135.8%   
Share capital Rs m16650 332.0%   
"Free" reserves Rs m6,286942 667.0%   
Net worth Rs m6,4551,716 376.1%   
Long term debt Rs m00-   
Total assets Rs m8,8284,156 212.4%  
Interest coverage xNMNM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.21.1 104.3%   
Return on assets %8.6-0.1 -7,018.8%  
Return on equity %11.8-0.3 -3,963.8%  
Return on capital %17.10-  
Exports to sales %8.35.7 145.3%   
Imports to sales %21.06.5 325.6%   
Exports (fob) Rs m869270 321.8%   
Imports (cif) Rs m2,209306 721.3%   
Fx inflow Rs m959375 256.0%   
Fx outflow Rs m2,612470 555.6%   
Net fx Rs m-1,653-96 1,730.2%   
CASH FLOW
From Operations Rs m1,070-8 -13,214.8%  
From Investments Rs m-750-146 514.6%  
From Financial Activity Rs m-150862 -17.4%  
Net Cashflow Rs m171709 24.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 75.0 69.1%  
Indian inst/Mut Fund % 18.2 0.3 6,066.7%  
FIIs % 1.0 15.7 6.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 9.1 319.8%  
Shareholders   28,591 12,856 222.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  FULFORD INDIA  ALEMBIC PHARMA  ELDER PHARMA  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 23, 2017 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE MERCK LTD WITH

MARKET STATS